Trinity to discuss acquisition in conference call
Trinity Biotech will host a conference call to discuss its recent acquisition of bioMerieux’s coagulation division at 4pm Irish time today.
Trinity, listed on the ISEQ and on the NASDAQ, is a developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets.